Nurix Therapeutics (NRIX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Nurix Therapeutics (NRIX) Company Statistics | The Fly

Nurix Therapeutics

· NRIX

Dashboard

Financials

KPIs

Ratios

Valuation

Statistics

2.457 B

+0.15%

General

Market Cap: $2.46B
Enterprise Value: $2.45B
Shares Outstanding: 103,780,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: -165.51%
Operating Margin: -982.37%
Net Profit Margin: -928.44%
FCF Margin: -828.28%
ROA: -63.74%
ROE: -76.09%
ROIC: -77.32%
Current Ratio: 6.34
Debt-to-Equity: 0.14
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.21
P/S: 66.93
P/FCF: —
P/B: 6.11
EV/EBITDA: -7.67

Growth

Rev 1Y: 53.95%
Rev 1Y Fwd Est: -18.49%
Rev 3Y (CAGR): 29.55%
Rev 5Y (CAGR): 36.35%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $36.77M
Gross Margin: -165.51%
Operating Expenses: $300.33M
Operating Income: -$361.18M
Net Profit: -$341.35M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $67.69M
Working Capital: $384.46M
Total Assets: $535.54M
Net Debt: -$9.54M
Total Liabilities: $132.91M
Total Equity: $402.63M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$293.7M
Cash Flow from Investing: $19.99M
Cash Flow from Financing: $257.2M
Free Cash Flow: -$304.53M
Capital Expenditures: $10.82M